Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Sanofi (SNY) Receivables - Other (2016 - 2025)

Sanofi's Receivables - Other history spans 11 years, with the latest figure at $1.7 billion for Q4 2025.

  • On a quarterly basis, Receivables - Other rose 11.49% to $1.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 billion, a 11.49% increase, with the full-year FY2025 number at $1.7 billion, up 11.49% from a year prior.
  • Receivables - Other hit $1.7 billion in Q4 2025 for Sanofi, up from $1.5 billion in the prior quarter.
  • Over the last five years, Receivables - Other for SNY hit a ceiling of $1.7 billion in Q4 2025 and a floor of $307.7 million in Q4 2021.
  • Historically, Receivables - Other has averaged $1.1 billion across 5 years, with a median of $1.5 billion in 2024.
  • Biggest five-year swings in Receivables - Other: surged 416.2% in 2021 and later fell 0.82% in 2024.
  • Tracing SNY's Receivables - Other over 5 years: stood at $307.7 million in 2021, then grew by 9.41% to $336.7 million in 2022, then surged by 362.74% to $1.6 billion in 2023, then decreased by 0.82% to $1.5 billion in 2024, then grew by 11.49% to $1.7 billion in 2025.
  • Business Quant data shows Receivables - Other for SNY at $1.7 billion in Q4 2025, $1.5 billion in Q4 2024, and $1.6 billion in Q4 2023.